Currently as Lead Serialisation Expert as Delpharm Poznan responsible for all serialization. In Delpharm so far managed to implement new site serialization solution (L3 system) after site was divested and left GSK network and also responsible for new serialization market implementation like China, Brazil, Bahrain, Turkey, Argentina, Indonesia, Kazakhstan, Uzbekistan and Hong Kong.

Delpharm has grown through the acquisition of plants from major big pharmas. With more than 1 billion units produced per year in a wide range of dosage forms, Delpharm is among the key drug manufacturers in the world. All the more, Delpharm is fully dedicated to pharma services for others : 100% of the turnover is for manufacturing and development for its customers. Priority is always given to customers.